Toxic hepatitis induced by infliximab in a patient with rheumatoid arthritis with no relapse after switching to etanercept
- 16 April 2009
- journal article
- case report
- Published by Springer Science and Business Media LLC in Clinical Rheumatology
- Vol. 28 (8), 1001-1003
- https://doi.org/10.1007/s10067-009-1179-y
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Infliximab-induced hepatitis: absence of cross-toxicity with etanerceptJoint Bone Spine, 2008
- Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safetyBMC Musculoskeletal Disorders, 2008
- The comparative one‐year performance of anti–tumor necrosis factor α drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: Results from a longitudinal, observational, multicenter studyArthritis Care & Research, 2008
- Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's diseaseCochrane Database of Systematic Reviews, 2008
- Successful treatment with etanercept in a patient with hepatotoxicity closely related to infliximabClinical Rheumatology, 2006
- Hepatitis: a rare, but important, complication of infliximab therapy for psoriasisClinical and Experimental Dermatology, 2006
- Hepatitis inducida por infliximab en un paciente con enfermedad de crohnGastroenterología y Hepatología, 2006
- Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritisAnnals Of The Rheumatic Diseases, 2005
- The efficacy of switching from etanercept to infliximab in patients with rheumatoid arthritis.2004
- Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexateAnnals Of The Rheumatic Diseases, 2003